Choroby układu krążenia— wyzwanie dla biotechnologii
Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS
The significance of thromboembolic complications in the etiology and development of cardiovascular diseases, such as ischaemic heart disease or myocardial infarction, is undisputableand well documented. It is commonly believed that intravascular thrombi may cause vesselnarrowing and even lead to complete vessel occulsion. When encountering circulation, narrowingof vascular lumen, such as intravascular clots and platelet aggregates, is believed to result inthromboembolisms. Activation of the fibrinolytie system allows for the proteolysis of fibrin clots,the main components of vascular thrombi, and thus it may lead to vascular reperfusion.
Biotechnologia, vol.44, 1 (1999)-.
0860-7796 ; oai:rcin.org.pl:143447 ; IChB B-40
Library of Institute of Bioorganic Chemistry PAS
Creative Commons Attribution BY-SA 4.0 license
Institute of Bioorganic Chemistry of the Polish Academy of Science
Institute of Bioorganic Chemistry of the Polish Academy of Science
18 lis 2020
19 paź 2020
312
https://rcin.org.pl/ichb/publication/178636
Nazwa wydania | Data |
---|---|
Choroby układu krążenia— wyzwanie dla biotechnologii | 18 lis 2020 |
Borkowska, Bożenna
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Pietrucha, Tadeusz Watała, Cezary